Overview of REJOIN: A Clinical Trial to Use Exercise to Relieve Joint Pain in Older Breast Cancer Survivors. (16th December 2020)

• Record Type: Journal Article
• Authors: Bluethmann, Shirley; Truica, Cristina; Olsen, Nancy; Sciamanna, Christopher; Klepin, Heidi; Chinchilli, Vernon; Schmitz, Kathryn
• Is Part Of: Innovation in aging. Volume 4(2020)Supplement 1
• Page Start: 650
• Page End: 650
• Publication Date: 2020-12-16
• Subjects: Aging -- Periodicals; Gerontology -- Periodicals; 612.67
• DOI: 10.1093/geroni/igaa057.2239
• Languages: English
• ISSNs: 2399-5300

Abstract

Abstract: Aromatase Inhibitors (AIs) are recommended for survival in hormone-sensitive breast cancer survivors, yet are underutilized, especially in older survivors. Joint pain is a prevalent AI-related symptom that is associated with low adherence. The aims for this randomized clinical trial (n=76) are to: 1) adapt a self-management (exercise + education) intervention for older survivors planning to take AIs; 2) Test the effect of a pilot intervention on arthralgia; and 3) Test its effect on AI medication adherence behaviors. We will adapt a program for seniors that includes bi-weekly 60-minute sessions of supervised exercise plus 30 minutes of education. The 16-week program includes: 8-weeks in person plus 8-weeks at home with phone counseling. We will conduct geriatric plus baseline assessment of exercise, joint pain, and AI adherence (repeated 4, 6 and 12 months). More research with geriatric survivors is required to address treatment needs and to promote survival. Part of a symposium sponsored by the Cancer and Aging Interest Group.